Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.90
-0.09 (-0.90%)
May 8, 2025, 4:00 PM - Market closed

Theravance Biopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
65.2764.3857.4251.3555.3171.86
Upgrade
Revenue Growth (YoY)
6.11%12.12%11.84%-7.17%-23.03%-2.12%
Upgrade
Cost of Revenue
40.1337.6440.6263.39193.66260.95
Upgrade
Gross Profit
25.1426.7416.8-12.05-138.35-189.1
Upgrade
Selling, General & Admin
70.869.1770.167.0799.3108.53
Upgrade
Operating Expenses
70.869.1770.4567.0799.3108.53
Upgrade
Operating Income
-45.66-42.44-53.65-79.12-237.64-297.63
Upgrade
Interest Expense
-2.56-2.55-2.35-6.37-8.55-8.55
Upgrade
Interest & Investment Income
4.984.989.026.742.014.74
Upgrade
Currency Exchange Gain (Loss)
-0.1-0.10.1-0.9-0.9-0.3
Upgrade
Other Non Operating Income (Expenses)
-0.5-----1.61
Upgrade
EBT Excluding Unusual Items
-43.84-40.1-46.88-79.65-245.08-303.34
Upgrade
Merger & Restructuring Charges
---2.39-12.84-20.14-
Upgrade
Gain (Loss) on Sale of Assets
---2.71--
Upgrade
Asset Writedown
-4.51-4.51----
Upgrade
Other Unusual Items
----3.03--
Upgrade
Pretax Income
-48.35-44.61-49.27-92.82-265.22-303.34
Upgrade
Income Tax Expense
9.9811.85.920.01-0.15-8.52
Upgrade
Earnings From Continuing Operations
-58.33-56.42-55.19-92.82-265.07-294.82
Upgrade
Earnings From Discontinued Operations
---964.9665.6516.81
Upgrade
Net Income
-58.33-56.42-55.19872.13-199.43-278.02
Upgrade
Net Income to Common
-58.33-56.42-55.19872.13-199.43-278.02
Upgrade
Shares Outstanding (Basic)
494955746962
Upgrade
Shares Outstanding (Diluted)
494955746962
Upgrade
Shares Change (YoY)
-4.72%-11.67%-24.85%5.95%11.41%12.11%
Upgrade
EPS (Basic)
-1.19-1.15-1.0011.85-2.87-4.46
Upgrade
EPS (Diluted)
-1.19-1.15-1.0011.85-2.87-4.46
Upgrade
Free Cash Flow
--11.87-29.49-187.56-211.26-257.02
Upgrade
Free Cash Flow Per Share
--0.24-0.53-2.55-3.04-4.12
Upgrade
Gross Margin
38.52%41.53%29.26%-23.46%-250.12%-263.16%
Upgrade
Operating Margin
-69.96%-65.91%-93.43%-154.09%-429.65%-414.19%
Upgrade
Profit Margin
-89.38%-87.63%-96.11%1698.54%-360.55%-386.90%
Upgrade
Free Cash Flow Margin
--18.43%-51.35%-365.29%-381.96%-357.68%
Upgrade
EBITDA
-43.6-40.73-51.65-76.08-232.83-294
Upgrade
EBITDA Margin
-66.81%-63.26%-89.94%-148.18%--
Upgrade
D&A For EBITDA
2.061.7123.044.813.63
Upgrade
EBIT
-45.66-42.44-53.65-79.12-237.64-297.63
Upgrade
EBIT Margin
-69.96%-65.91%-93.43%-154.09%--
Upgrade
Revenue as Reported
65.2764.3857.4251.3555.3171.86
Upgrade
Advertising Expenses
-4.35.189.36.3
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q